Crackdown On Substandard Ayurvedic Medicines

THIRUVANANTHAPURAM: Various batches of ayurvedic medicines of Rajasthan Herbal International Pvt Ltd have been found to be of substandard quality during quality tests conducted at the drug testing laboratories of the State Drugs Controller’s Department. Following this, the Ayurvedic Drugs Control Department banned the distribution and sale of these medicines.

 

Traders and hospitals holding stock of drugs should return the same to the distributor and inform the District Ayurvedic Drugs Inspectors concerned, the officials said. Name and batch number of medicines are: Pain Niwaran Churna (PNF21057), Dr Relaxi Capsule (DRG21019), Pain Niwaran Churna (PNK21089), Mood on Forever (MCE21003), Dr Relaxi Capsule (DRK21030), Dr Relaxi Oil (DOD21004), Dama Buti Churna (DBH21017), Asthalex Capsule (ALK21004).

Related Posts

Apollo Navi Mumbai launches geriatric oncology clinic

With a dedicated Geriatric Oncology Clinic, Apollo Hospitals Navi Mumbai brings specialised geriatric cancer care to the private healthcare setting in Navi Mumbai. With the launch of the Geriatric Oncology…

Maharashtra FDA cancels licences of 62 pharma units, 141 chemist shops

Mumbai: The Food and Drug Administration (FDA) has cracked down on medical stores violating drug-sale rules, suspending 599 licences and cancelling another 141 after inspecting 2,295 retail establishments across the…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Apollo Navi Mumbai launches geriatric oncology clinic

Apollo Navi Mumbai launches geriatric oncology clinic

Maharashtra FDA cancels licences of 62 pharma units, 141 chemist shops

Maharashtra FDA cancels licences of 62 pharma units, 141 chemist shops

Himachal DCA honoured with ‘Regulatory Excellence Award’ at iPHEX 2026

Himachal DCA honoured with ‘Regulatory Excellence Award’ at iPHEX 2026

Baddi pharma firm loses licence after 1,200-kg tapentadol haul

Baddi pharma firm loses licence after 1,200-kg tapentadol haul

US FDA takes steps to maintain newborn access to life-saving starter nutrition products

US FDA takes steps to maintain newborn access to life-saving starter nutrition products

Mankind Pharma launches campaign to inspire 1 crore Indians to pledge for organ donation